Serina Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $130 | $0 | $-14 |
Gross Profit | -17 | 114 | -17 | -14 |
EBITDA | -4,572 | -6,437 | -4,805 | -2,679 |
EBIT | -4,589 | -6,453 | -4,822 | -2,735 |
Net Income | -4,585 | -6,448 | -4,813 | -2,740 |
Net Change In Cash | 0 | 130 | 0 | -14 |
Free Cash Flow | -3,863 | -3,750 | -4,322 | -4,594 |
Cash | 8,620 | 6,041 | 4,267 | 3,672 |
Basic Shares | 10,339 | 10,004 | 9,756 | 10,751 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $56 | $3,153 | $500 | $3,039 |
Gross Profit | -138 | 3,063 | 500 | 3,039 |
EBITDA | -10,487 | 5,917 | -2,604 | -1,228 |
EBIT | -10,681 | 5,827 | -2,666 | -1,261 |
Net Income | -11,141 | 5,269 | -2,682 | -1,264 |
Net Change In Cash | 56 | 3,153 | 500 | 3,039 |
Free Cash Flow | -17,159 | -2,980 | -2,085 | -2,359 |
Cash | 3,672 | 7,619 | 645 | 584 |
Basic Shares | 7,359 | 8,413 | 1,078 | 1,077 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.51 |
2025-06-30 | -$0.66 |
2025-03-31 | -$0.49 |
2024-12-31 | -$0.35 |
